Scott D. Rand
0000-0002-4136-9352
Publication & Citation Trends
Publications
0 total
Pulsed reduced dose rate radiotherapy in conjunction with bevacizumab significantly extends survival over bevacizumab alone in recurrent high-grade glioma. OA
Cited by 13
Semantic Scholar
Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low–Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors OA
Cited by 41
Semantic Scholar
NIMG-28. VALIDATION OF SINGLE-DOSE DSC-MRI PROTOCOLS FOR ROBUST PERFUSION ASSESSMENT IN BRAIN TUMORS OA
Cited by 0
Semantic Scholar
Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial OA
Cited by 17
Semantic Scholar
Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project OA
Cited by 44
Semantic Scholar
Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency OA
Cited by 65
Semantic Scholar
Quantifying metal‐induced susceptibility artifacts of the instrumented spine at 1.5T using fast‐spin echo and 3D‐multispectral MRI OA
Cited by 14
Semantic Scholar
Acid ceramidase is a novel drug target for pediatric brain tumors OA
Cited by 31
Semantic Scholar
Research Topics
Advanced MRI Techniques and Applications
(32)
MRI in cancer diagnosis
(32)
Glioma Diagnosis and Treatment
(27)
Advanced Neuroimaging Techniques and Applications
(13)
Radiomics and Machine Learning in Medical Imaging
(10)
Affiliations
Northeastern University
Froedtert Hospital
MACOM (United States)
City University of New York
University of Washington